Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of the National Cancer Institute

• Publication date

  1999-12-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/jnci/91.24.2081PMID 28158646
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Interactions entre le carboplatine, le cisplatine et les rayonnements ionisants dans une lignée cellulaire humaine de cancer ovarien*

  1999cited by this paper
• Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer.

  1998cited by this paper
• Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice?

  1997cited by this paper
• Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials.

  1997cited by this paper
• A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results

  1997cited by this paper
• Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial.

  1997cited by this paper
• Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group.

  1996cited by this paper
• Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials.

  1996cited by this paper
• [The radiochemotherapy of advanced head-neck tumors--what is certain?].

  1996cited by this paper
• Radiothérapie hyperfractionnée et accélérée dans les cancers de la tête et du cou: résultats des essais de l'EORTC et impact sur la pratique clinique

  1996cited by this paper
• An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer.

  1995cited by this paper
• Irradiation-enhanced binding of carboplatin to DNA.

  1995cited by this paper
• Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer.

  1994cited by this paper
• Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer.

  1994cited by this paper
• Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy.

  1992cited by this paper
• Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy.

  1992cited by this paper
• Simultaneous chemoradiation in the treatment of advanced head and neck cancer.

  1992cited by this paper
• Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. The final report of a randomized trial

  1991cited by this paper
• Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.

  1991cited by this paper
• Ten-year results of randomized trial comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx: experience of the European Organization for Research and Treatment of Cancer.

  1988cited by this paper
• Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial.

  1987cited by this paper
• A randomised clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer.

  1987cited by this paper
• Dose Specification for Reporting External Beam Therapy with Photons and Electrons

  1979cited by this paper

• Tumors of the head and neck: ways to improve the results of conservative therapy. Part II. Oropharyngeal cancer

  2026cites this paper
• Transoral Robotic Surgery in the Multidisciplinary Care of Patients With Oropharyngeal Squamous Cell Carcinoma: ASCO Guideline

  2025cites this paper
• Meta-analysis to Investigate the Correlation Between Event-Free Survival and Overall Survival in Patients with Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

  2025cites this paper
• Matched-Pair Analysis of Survival in the Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Radiotherapy or Concurrent Chemoradiotherapy Versus Surgical-Based Treatment

  2025cites this paper
• A Targeted Approach to Dental Treatment for Patients Prior To and After Head and Neck Radiation

  2025cites this paper
• P16/HPV-negative oropharyngeal squamous cell carcinoma survival: Comparing primary surgery to primary chemoradiotherapy. A systematic review and meta-analysis.

  2025cites this paper
• Phase 2 Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Long-term Follow-up of NRG Oncology Radiation Therapy Oncology Group Protocol 9911

  2025cites this paper
• Spatially precise chemo-radio-immunotherapy by antibody drug conjugate directed tumor radiosensitization to potentiate immunotherapies

  2025cites this paper
• De-escalated adjuvant radiotherapy versus standard adjuvant treatment for human papillomavirus-associated oropharyngeal squamous cell carcinoma (MC1675): a phase 3, open-label, randomised controlled trial.

  2025cites this paper
• Recent progress in the treatment of locally advanced head and neck squamous cell carcinomas

  2025cites this paper
• The Change in Paradigm for Surgical Management of HPV-positive Oropharynx Cancer.

  2025cites this paper
• Unraveling the Role of Tumor-Infiltrating Immune Cells in Head and Neck Squamous Cell Carcinoma: Implications for Antitumor Immune Responses and Immunotherapy

  2025cites this paper
• Monoclonal Antibodies in Clinical Trials for Breast Cancer Treatment

  2025cites this paper
• Detecting Extranodal Extension in HPV‐Related Oropharyngeal Cancer via Machine Learning

  2025cites this paper
• The role of surgery and deescalation for HPV‐related oropharyngeal cancer

  2024cites this paper
• Advances in Foxp3+ regulatory T cells (Foxp3+ Treg) and key factors in digestive malignancies

  2024cites this paper
• The Effect of Care Training Intervention on Oral Health and Radiation-Induced Xerostomia in Patients with Head and Neck Cancer: A Quasi-Experimental Study

  2024cites this paper
• Airway protection and outcomes after staged versus concurrent bilateral neck dissections with transoral base of tongue cancer resection

  2024cites this paper
• Outcomes of postoperative radiotherapy combined with or without chemotherapy for locally advanced oral cancer: a systematic review and meta-analysis

  2024cites this paper
• Verbesserte Schluckfunktion nach definitiver Radiochemotherapie bei Oro- und Hypopharynxkarzinomen durch Schonung der Musculi constrictores pharyngis

  2024cites this paper
• The effect of skeletal muscle mass on dose-limiting toxicities during (chemo)radiotherapy in patients with head and neck cancer: A systematic review and meta-analysis.

  2024cites this paper
• Missed Adjuvant Therapy in Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma

  2024cites this paper
• How do patients with head and neck cancer and low skeletal muscle mass experience cisplatin-based chemoradiotherapy? A qualitative study

  2024cites this paper
• Preservación de órgano en tumores de cabeza y cuello

  2024cites this paper
• Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head and Neck (SCCHN)

  2023cites this paper
• Verbesserte Schluckfunktion nach definitiver Radiochemotherapie bei Oro- und Hypopharynxkarzinomen durch Schonung der Musculi constrictores pharyngis

  2023cites this paper
• Enteral Nutrition during Radiotherapy for Oropharyngeal Cancers: Prevalence and Prognostic Factors Based on HPV Status (A GETTEC Study)

  2023cites this paper
• Oropharyngeal Carcinoma with a Special Focus on HPV-Related Squamous Cell Carcinoma

  2023cites this paper
• Complications following salvage transoral robotic surgery with and without reconstruction: A systematic review of the literature.

  2023cites this paper
• A rare case of peritoneal metastases from oropharyngeal squamous cell carcinoma in a young male after completion of chemoradiotherapy

  2023cites this paper
• Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma.

  2023cites this paper
• Oral health-related quality of life after radiation therapy for head and neck cancer: the OraRad study

  2023cites this paper
• Robotic Surgery in the Head and Neck: Presurgical Considerations and Post-treatment Appearance.

  2023cites this paper
• Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma.

  2023cites this paper
• De-escalation for Human Papillomavirus–Associated Oropharyngeal Cancer

  2023cites this paper
• Prognostic stratification of HPV associated oropharyngeal cancer based on CD103+ immune cell abundance in patients treated on TROG 12.01 and De-ESCALaTE randomised trials.

  2022cites this paper
• Cost-effectiveness of concurrent radiation with cetuximab or chemotherapy in older patients with oropharyngeal cancer.

  2022cites this paper
• Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer

  2022cites this paper
• Impact of a mobile application (reminder app) on acute toxicity during radiotherapy of head-and-neck cancer – results of a randomized phase III trial (RAREST-02)

  2022cites this paper
• An Overview of Clinical Oncology and Impact on Oral Health

  2022cites this paper
• Historical Perspective: How the Discovery of HPV Virus Led to the Utilization of a Robot

  2022cites this paper
• Survival Outcomes Related to Treatment Modalities in Patients With Oropharyngeal Squamous Cell Carcinoma

  2022cites this paper
• Upfront DPYD Genotyping and Toxicity Associated with Fluoropyrimidine-Based Concurrent Chemoradiotherapy for Oropharyngeal Carcinomas: A Work in Progress

  2022cites this paper
• Comparing the M.D. Anderson Symptom and Dysphagia Inventories for Head and Neck Cancer Patients

  2022cites this paper
• Therapeutic approaches for the treatment of head and neck squamous cell carcinoma–An update on clinical trials

  2022cites this paper
• Chemoradiotherapy with high‐dose cisplatin compared with weekly cisplatin for locally advanced head and neck squamous cell carcinoma

  2021cites this paper
• Comorbidity, Radiation Duration, and Pretreatment Body Muscle Mass Predict Early Treatment Failure in Taiwanese Patients with Locally Advanced Oral Cavity Squamous Cell Carcinoma after Completion of Adjuvant Concurrent Chemoradiotherapy

  2021cites this paper
• Current status of systemic therapy in head and neck cancer

  2021influential citation
• Optimal Supportive Measures during Primary Treatment

  2021cites this paper
• Trends in Cancer Treatment for Oral Cavity, Oropharynx, and Larynx in 2016 Versus 2009: SEER Patterns of Care Studies

  2021cites this paper
• [Predictive factors for mandibular osteoradionecrosis after irradiation of head and neck cancers].

  2021cites this paper
• Oral Cavity and Oropharyngeal Cancer: Treatment

  2021cites this paper
• Long-Term Survival Following Palliative Chemoradiotherapy in an Elderly Patient With Advanced Squamous Cell Carcinoma in the Right Mandibular Gingiva

  2021cites this paper
• Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.

  2021cites this paper
• Review of the Terminology Describing Ionizing Radiation-Induced Skin Injury: A Case for Standardization

  2021cites this paper
• Patient Selection for Transoral Robotic Surgery (TORS) in Oropharyngeal Squamous Cell Carcinoma: What the Surgeon Wants to Know.

  2021cites this paper
• American Radium Society™ Appropriate Use Criteria on Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer.

  2021cites this paper
• Stereotactic radiotherapy as planned boost after definitive radiotherapy for head and neck cancers: Systematic review

  2021cites this paper
• Therapeutic strategies for systemic therapies of human papillomavirus‐related oropharyngeal cancer

  2021cites this paper
• Oncologic outcomes of transoral robotic surgery for HPV‐negative oropharyngeal carcinomas

  2021cites this paper
• Assessment of Predictive Scoring System for 90-Day Mortality Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Completed Concurrent Chemoradiotherapy

  2020cites this paper
• Treatment-Related Patient Outcomes for Head and Neck Cancer

  2020cites this paper
• Principles of Management of Head and Neck Cancers

  2020cites this paper
• Combining Chk1/2 inhibition with radiation in head and neck cancer

  2020cites this paper
• Características clínicas da metástase do carcinoma de células escamosas oral

  2020cites this paper
• Comparison of Carboplatin With 5-Fluorouracil vs. Cisplatin as Concomitant Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

  2020cites this paper
• Novel Strategies to Effectively De-escalate Curative-Intent Therapy for Patients With HPV-Associated Oropharyngeal Cancer: Current and Future Directions.

  2020cites this paper
• Translating Targeted Radiosensitizers into the Clinic

  2020cites this paper
• HPV-positive oropharyngeal cancers: Today and tomorrow

  2020cites this paper
• The Slippery Role of Induction Chemotherapy in Head and Neck Cancer: Myth and Reality

  2020cites this paper
• Induction chemotherapy in nonlaryngeal human papilloma virus-negative high-risk head and neck cancer: a real-world experience

  2020cites this paper
• Overview of head and neck cancer management

  2020cites this paper
• Outcomes in N3 Head and Neck Squamous Cell Carcinoma and Role of Upfront Neck Dissection

  2020cites this paper
• Outcomes after salvage for HPV-positive recurrent oropharyngeal cancer treated with primary radiation.

  2020cites this paper
• Current Indications for Transoral Robotic Surgery in Oropharyngeal Cancer.

  2020cites this paper
• Most Cited Articles in Head and Neck Oncology

  2020cites this paper
• Combining radiation and chemotherapy to improve the therapeutic ratio

  2020cites this paper
• Machine Learning Prediction of Extracapsular Extension in Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma

  2020cites this paper
• Cancer of the Head and Neck

  2020cites this paper
• Squamous cell carcinoma of head and neck: what internists should know

  2020cites this paper
• Addition of chemotherapy to hyperfractionated radiotherapy in advanced head and neck cancer—a meta-analysis

  2019cites this paper
• Role of pretreatment fluorodeoxyglucose positron emission tomography quantitative parameters in prognostication of head-and-neck squamous cell carcinoma

  2019cites this paper
• The addition of chemotherapy to radiotherapy did not reduce the rate of distant metastases in low‐risk HPV‐related oropharyngeal cancer in a real‐world setting

  2019cites this paper
• Surgical Options for Locally Advanced Oropharyngeal Cancer

  2019cites this paper
• Platinum rechallenge in recurrent head and neck squamous cell carcinoma after primary chemoradiation.

  2019cites this paper
• Current treatment, particle radiotherapy, and boron neutron capture therapy for advanced oral cancer in patients

  2019cites this paper
• CTX-Induktion gefolgt von Cetuximab und Bestrahlung nicht effektiver als simultane RCT

  2019cites this paper
• Outcomes for elderly patients 75 years and older treated with curative intent radiotherapy for mucosal squamous cell carcinomas of the head and neck

  2019cites this paper
• Neck management in head and neck squamous cell carcinomas: where do we stand?

  2019cites this paper
• Factors associated with employment discontinuation among older and working age survivors of oropharyngeal cancer

  2019cites this paper
• Therapeutic Intensification and Induction Chemotherapy for High-Risk Locally Advanced Squamous Cell Carcinoma

  2019cites this paper
• Burden of treatment: Reported outcomes in a head and neck cancer survivorship clinic

  2019cites this paper
• Das Ende der TPF-Induktion bei lokoregionär fortgeschrittenen HNO-Karzinomen? Induktionschemotherapie gefolgt von Cetuximab und Bestrahlung nicht effektiver als simultane Radiochemotherapie

  2019cites this paper
• The 100 most cited manuscripts in head and neck cancer: a bibliometric analysis.

  2019cites this paper
• Rechallenge en sels de platine après radiochimiothérapie pour les récidives de carcinome épidermoïde des voies aérodigestives supérieures

  2019cites this paper
• Phase 2 Randomized Study of Radiation Therapy and 3-Year Androgen Deprivation With or Without Concurrent Weekly Docetaxel in High-Risk Localized Prostate Cancer Patients.

  2019cites this paper
• Head and Neck Cancers

  2019cites this paper
• Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice

  2019cites this paper
• Radiation Modifiers.

  2019cites this paper
• The changing therapeutic landscape of head and neck cancer

  2019cites this paper